Concepedia

Publication | Open Access

Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

DOIFull Paper Access

206

Citations

17

References

1996

Year

Philippe Ruszniewski, Michel Ducreux, Jean‐Alain Chayvialle, Joëlle Blumberg, D Cloarec, H Michel, Jean Michel Raymond, J L Dupas, H Gouérou, Raymond Jian,
Gut

Abstract

Lanreotide, 30 mg intramuscularly every other week, is an effective and convenient treatment in patients with the carcinoid syndrome.

References

YearCitations

Page 1